Reach Us +1-218-451-2974


Xin Xu | OMICS International
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2245

Journal of Alzheimers Disease & Parkinsonism received 2245 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Xin Xu

Xin Xu Applied Cognitive Research Loughborough University UK


Dr. Xin Xu working in Psychology Division, School of Sport, Exercise and Health Sciences, Loughborough University, UK. He was previous worked for Memory, Ageing and Cognition Center, National University of Singapore.

His reaserch inrest Hopkins verbal learning test; Mild cognitive impairment; Dementia. With an advancing age, there is an average decline in various areas of cognitive function, such as episodic memory and speed of complex information processing. Dementia is a separate progressive neurodegenerative disorder that causes a severe decline in memory and other cognitive abilities, which have a significant impact on the quality of life. There is currently no effective treatment. Globally, the number of people afflicted with dementia has shown a steady growth over the last decades. Mild cognitive impairment (MCI) is defined as cognitive decline worse than that of those who have a similar advanced age, but which causes no interference with activities of daily life, such as dementia does. The most commonly used MCI diagnostic criteria were developed by Petersen et al. and confer an increased risk for dementia



Global Speakers in the subject

Global Experts in the subject